Estimating Glomerular Filtration Rate in Kidney Transplant Recipients
Performances of Estimated Glomerular Filtration Rate Equations in Kidney Transplant Recipients
1 other identifier
observational
11,412
4 countries
10
Brief Summary
Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native kidneys, but their performances in transplant kidney population remains unknown. We aimed at developing a kidney-transplant-specific GFR equation, and comparing its performance to standard GFR equations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2000
Longer than P75 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 27, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2022
CompletedAugust 29, 2022
August 1, 2022
21 years
January 27, 2022
August 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measured glomerular filtration rate (mGFR)
Isotopic measurements of GFR
Up to 15 years after kidney transplantation
Study Arms (8)
Development cohort
kidney transplant recipients in 3 centres in France: Necker, Saint-Louis and Toulouse hospitals
Validation cohort 1
kidney transplant recipients from Montpellier Hospital, France
Validation cohort 2
kidney transplant recipients from Lyon Hospital, France
Validation cohort 3
kidney transplant recipients from Tenon Hospital, France
Validation cohort 4
kidney transplant recipients from Saint-Etienne Hospital, France
Validation cohort 5
kidney transplant recipients from Mayo Clinic Hospital, USA
Validation cohort 6
kidney transplant recipients from Bergamo hospital, Italy
Validation cohort 7
kidney transplant recipients from Zagreb hospital, Croatia
Interventions
Kidney recipients aged over 18 and of all sexes recruited from 2000 who have mGFR follow-up and clinical, biological, and immunological data
Eligibility Criteria
The development cohort consisted of kidney transplant recipients from 3 centres in France. The validation cohorts consisted kidney transplant recipients from 6 centers in Europe and 1 in the Unites states.
You may qualify if:
- Living or deceased donor kidney recipient transplanted between 01/01/2000 and 01/01/2021.
- Men or women over 18 years of age.
- Written informed consent at the time of transplantation for the center database.
You may not qualify if:
- Combined transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
William J. von Liebig Centre for Transplantation and Clinical Regeneration, Mayo Clinic
Rochester, Minnesota, United States
Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School of Medicine, University of Zagreb
Zagreb, Croatia
Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon
Lyon, France
Department of Nephrology, Centre Hospitalier Universitaire, Montpellier
Montpellier, France
Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris
Paris, France
Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris
Paris, France
Kidney Transplant Department, Tenon Hospital, Assistance Publique - Hôpitaux de Paris
Paris, France
Nephrology, Dialysis and Renal Transplantation Department, Hôpital Nord, CHU de Saint-Etienne, Jean Monnet University, Université de Lyon
Saint-Etienne, France
Department of Nephrology and Organ Transplantation, CHU Rangueil
Toulouse, France
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Bergamo, Italy
Related Publications (1)
Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prie D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L, Ibrahim HN, Nielsen MB, Matas AJ, Nankivell BJ, Benjamens S, Pol RA, Bakker SJL, Jouven X, Legendre C, Kamar N, Smith BH, Wadei HM, Durrbach A, Vincenti F, Remuzzi G, Lefaucheur C, Bentall AJ, Loupy A. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study. BMJ. 2023 May 31;381:e073654. doi: 10.1136/bmj-2022-073654.
PMID: 37257905DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Loupy, MD, PhD
Paris Translational Research Center for Organ Transplantation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2022
First Posted
February 8, 2022
Study Start
January 1, 2000
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
August 29, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share